A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis

British Journal of Dermatology

Volumn 153, Issue 3, 2005, Pages 613-619

  Dawe, Robert S ^a   Yule, S ^a   Cameron, H ^a   Moseley, H ^a   Ibbotson, S H ^a   Ferguson, J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Balneotherapy; Dead Sea salt; Narrowband ultraviolet B; Phototherapy; Psoriasis; Randomized controlled trial

Indexed keywords

DIPROBASE; DOUBLEBASE; EMOLLIENT AGENT; PSORALEN; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BALNEOTHERAPY; CHRONIC PLAQUE PSORIASIS; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEAD SEA SALT BALNEOPHOTOTHERAPY; DISEASE SEVERITY; ERYTHEMA; EUROPE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SKIN EXAMINATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

ADULT; AGED; AREA UNDER CURVE; BATHS; DOSE-RESPONSE RELATIONSHIP, RADIATION; ERYTHEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MINERAL WATERS; PSORIASIS; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SODIUM CHLORIDE; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 24344441626     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06663.x     Document Type: Article

References (35)

1. British Photodermatology Group. An appraisal of narrowband (TL-01) UVB phototherapy. British Photodermatology Group Workshop Report (April, 1996). Br J Dermatol 1997; 133:327-30.
2. Dawe RS. A quantitative review of studies comparing the efficacy of narrow-band and broad-band ultraviolet B for psoriasis. Br J Dermatol 2003; 149:669-72.
3. Schiffner R, Schiffner-Rohe J, Wölfl G et al. Evaluation of a multicentre study of synchronous application of narrowband ultraviolet B phototherapy (TL-01) and bathing in Dead Sea salt solution for psoriasis vulgaris. Br J Dermatol 2000; 142:740-7.
4. Stander M. [Thermo-sodium phototherapy of psoriasis vulgaris]. Fortschr Med 1983; 101:931-6.
5. Stander M. [Experience with the Thermalsole-phototherapy in psoriasis vulgaris]. Hautarzt 1978; 29:328-30.
6. Streit V, Wiedow O, Christophers E. Innovative Balneotherapie mit reduzierten Badevolumina. Folienbader Hautarzt 1993; 213:140-4.
7. Kaufmann J, Meves C. Psoriasis-Kurerfolg am Toten Meer (Israel). Resultate und Eindrucke von 11 Patienten. Schweiz Rundsch Med Prax 1974; 136:957-8.
8. Sapeika N. Treatment of psoriasis at the Dead Sea. S Afr Med J 1976; 50:2021.
9. Montgomery BJ. Bathing for psoriasis in the Dead Sea. JAMA 1978; 17:227-31.
10. Even-Paz Z, Shani J. The Dead Sea and psoriasis. Historical and geographic background. Int J Dermatol 1988; 119:1-9.
11. Harari M, Shani J. Demographic evaluation of successful antipsoriatic climatotherapy at the Dead Sea (Israel) DMZ Clinic. Int J Dermatol 1996; 158:304-8.
12. Abels DJ, Kipnis V. Bioclimatology and balneology in dermatology: a Dead Sea perspective. Clin Dermatol 1998; 16:695-8.
13. Wiedow O, Wiese F, Streit V et al. Lesional elastase activity in psoriasis, contact dermatitis, and atopic dermatitis. J Invest Dermatol 1989; 40:306-9.
14. Wiedow O, Streit V, Christophers E, Stander M. Freisetzung von humaner Leukozytenelastase durch hypertone Salzbader bei Psoriasis. Hautarzt 1989; 40:518-22.
15. Boer J, Schothorst AA, Boom B et al. Influence of water and salt solutions on UVB irradiation of normal skin and psoriasis. Arch Dermatol Res 1982; 25:247-59.
16. Schempp CM, Müller K, Schulte-Mönting J et al. Der Einfluss verschiedener Salzlösungen auf die Ultraviolett-B-vermittelte Induktion von Erythem und Pigmentierung. Hautarzt 1998; 17:482-6.
17. Shani J, Sharon R, Koren R, Even-Paz Z. Effect of Dead-Sea brine and its main salts on cell growth in culture. Pharmacology 1987; 35:339-47.
18. Gruner S, Zwirner A, Boonen H, Sönnichsen N. Der Einfluss einer Behandlung mit Salz des Toten Meeres (Tomesa-Therapie) auf epidermale Langerhanszellen - eine klinische Studie. Z Hautkr 1990; 176:1146-51.
19. Schempp CM, Dittmar HC, Hummler D et al. Magnesium ions inhibit the antigen-presenting function of human epidermal Langerhans cells in vivo and in vitro. Involvement of ATPase, HLA-DR, B7 molecules, and cytokines. J Invest Dermatol 2000; 43:680-6.
20. Olafsson JH, Sigurgeirsson B, Pálasdóttir R. Psoriasis treatment: bathing in a thermal lagoon combined with UVB, versus UVB treatment only. Acta Derm Venereol (Stockh) 1996; 76:228-30.
21. Zimmermann J, Utermann S. Photosoletherapie bei Patienten mit Psoriasis und Neurodermitis atopica. Hautarzt 1994; 21:849-53.
22. Gambichler T, Rapp S, Senger E et al. Balneophototherapy of psoriasis: highly concentrated salt water versus tap water - a randomized, one-blind, right/left comparative study. Photodermatol Photoimmunol Photomed 2001; 17:22-5.
23. Hudson-Peacock MJ, Diffey BL, Farr PM. Photoprotective action of emollients in ultraviolet therapy of psoriasis. Br J Dermatol 1985; 13:361-5.
24. Lebwohl M, Martinez J, Weber P, DeLuca R. Effects of topical preparations on the erythemogenicity of UVB: implications for psoriasis phototherapy. J Am Acad Dermatol 1995; 51:469-71.
25. Dawe RS, Wainwright NJ, Cameron H, Ferguson J. Narrow-band (TL-01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment? Br J Dermatol 1998; 138:833-9.
26. Wainwright NJ, Dawe RS, Ferguson J. Narrowband ultraviolet B (TL-01) phototherapy for psoriasis: which incremental regimen? Br J Dermatol 1998; 139:410-14.
27. Dawe RS, Cameron H, Yule S et al. A randomized controlled trial of narrowband ultraviolet B vs. bath-psoralen plus ultraviolet A photochemotherapy for psoriasis. Br J Dermatol 2003; 148:1194-204.
28. Dawe RS, Cameron H, Yule S et al. UV-B phototherapy clears psoriasis through local effects. Arch Dermatol 2002; 138:1071-6.
29. Machin D, Campbell MJ, Fayers PM, Pinol APY. Comparing paired groups for binary, ordered categorical and continuous outcomes. In: Sample Size Tables for Clinical Studies, 2nd edn. Oxford: Blackwell Science, 1997; 69-98.
30. Ryan P. Random allocation of treatment in blocks. In: The Stata Technical Bulletin Reprints (Newton HJ, ed.). College Station, TX: Stata Corporation, 1997; 297-300.
31. Diffey BL, Oliver RJ, Farr PM. A portable instrument for quantifying erythema induced by ultraviolet radiation. Br J Dermatol 1984; 111:663-72.
32. Davidson AW. Calculation of erythema dose-response curves using a spreadsheet. Photodermatol Photoimmunol Photomed 1999; 15:104-8.
33. Ibbotson SH, Farr PM. The time-course of psoralen ultraviolet A (PUVA) erythema. J Invest Dermatol 1999; 113:346-50.
34. Kabat-Zinn J, Wheeler E, Light T et al. Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom Med 1998; 60:625-32.
35. Fortune DG, Richards HL, Kirby B et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003; 139:752-6.